Benzonatate Capsule
Product Images NDC 65841-614

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 65841-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

647424d0 F3b7 4128 8543 F0db0c994926 01

Label for Benzonatate Capsules, USP 100 mg, oral capsules supplied in a 100-count package. The label includes dosage instructions, storage conditions, and a caution to keep out of reach of children. Manufactured by Cadila Healthcare Ltd., Ahmedabad, India, and labeled by Zydus Pharmaceuticals. NDC 65841-614-01 is noted on the label.*

FDA Label Image

647424d0 F3b7 4128 8543 F0db0c994926 02

Label for Benzonatate Capsules USP 200 mg in a 100 capsule size, oral dosage form. The label includes usage storage instructions, manufacturer Cadila Healthcare Ltd., and highlights the prescription-only status. The Zydus Lifesciences Limited logo is present, and the NDC code is 65841-843-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.